Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis

Indianapolis, Indiana 45237

0 studies enrolling now · 1 studies all time

What they study most

Acute Myeloid Leukemia (AML), FMS-like Tyrosine Kinase-3 (FLT3) Mutations

Studies at this site

• Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD) — APPROVED_FOR_MARKETING